Dr. Civitelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Barnes West Dr
Ste 200
Saint Louis, MO 63141Phone+1 314-454-7775Fax+1 314-996-3087
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1988
- Univ Siena- Fac MedClass of 1980
Certifications & Licensure
- MO State Medical License 1989 - 2026
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2005
- Fuller Albright Award American Society for Bone and Mineral Research, 1995
- Kappa Delta Award American Academy of Orthopaedic Surgeons, 1994
- Join now to see all
Publications & Presentations
PubMed
- Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341Lvariant and study of organoids towards treatment.Ignacio Portales-Castillo, Rhea Singal, Anastasia Ambrose, Jong Hee Song, Minsoo Son
JIMD Reports. 2024-09-01 - Six drivers of aging identified among genes differentially expressed with age.Ariella Coler-Reilly, Zachary Pincus, Erica L Scheller, Roberto Civitelli
Biorxiv. 2024-08-06 - 2 citationsBone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength.Giulia Leanza, Francesca Cannata, Malak Faraj, Claudio Pedone, Viola Viola
Elife. 2024-04-10
Journal Articles
- Focusing on the Science: JBMR Manuscript Types*Roberto Civitelli, MD, Journal of Bone and Mineral Research
Press Mentions
- Nickolas to Lead Division of Bone and Mineral DiseasesSeptember 26th, 2024
- Bone Canonical Wnt Signaling Is Downregulated in Type 2 Diabetes and Associates with Higher Advanced Glycation End-Products (AGEs) Content and Reduced Bone StrengthApril 15th, 2024
Grant Support
- Metabolic Skeletal Disorders Training Program GrantNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011–2012
- Smad4/B-Catenin Signaling Cross-Talk For OsteoblastogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
- Cadherin Mediated Cell-Cell Interactions In The Bone MicroenvironmentNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
- Connexin 43 In Bone FormationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2011
- Cadherin Regulation Of Osteoblast FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2004
- Connexin 43 In Bone FormationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2003
- Cadherin Regulation Of Osteoblast FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–2002
- Biology Of Cell/Cell Communication In BoneNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2001
- Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2000
- Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1996
- Intercellular Communication In Bone Cell PhysiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992–1993
Professional Memberships
- Member
- American Society for Bone and Mineral ResearchMember
- American Society for Bone and Mineral ResearchPresident, 2014
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: